Department of Health Policy Archives
Study to explore how rising medication costs impact elderly
Aug. 9, 2018—As both drug prices and out-of-pocket expense for prescription medications continue to climb, a team of Health Policy experts at Vanderbilt University School of Medicine (VUSM) have received a grant to determine if these factors are causing older Americans enrolled in Medicare Part D for medication coverage to delay or never fill their prescriptions.
Team Hope program’s mission is to enhance care for newborns with NAS
Jul. 26, 2018—A collaborative program across units at Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt is changing the way nurses and doctors care for newborns diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS).
Integrated, multidisciplinary approach key to opioid fight: panel
Jul. 26, 2018—No single approach will end the epidemic of fatal overdoses caused by addiction to opioid painkillers and heroin that is ravaging this country, the U.S. Assistant Secretary for Health, Adm. Brett Giroir, MD, warned Tuesday during a panel discussion in a packed lecture hall at Vanderbilt University Medical Center.
Study shows legalizing same-sex marriage increased care access
Jul. 19, 2018—Vanderbilt researchers have documented evidence that legalizing same-sex marriage has improved access to health care for gay men in a study released as a National Bureau of Economic Research working paper this week.
Buntin visits the Hill
Jul. 12, 2018—Melinda Buntin, PhD, Mike Curb Professor and Chair of the Department of Health Policy, recently testified before the Senate Health, Education, Labor and Pensions Committee chaired by U.S. Sen. Lamar Alexander.
Study reveals opioid patients face multiple barriers to treatment
Jul. 12, 2018—In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.
Addressing the opioid crisis
May. 24, 2018—U.S. Surgeon General Jerome Adams, MD, MPH, visited Vanderbilt University Medical Center last week to speak at the spring Health Policy Grand Rounds at Langford Auditorium. The event was dedicated to combatting America’s opioid crisis, and Adams emphasized the importance of the overdose-reversal drug naloxone.
Early discharge of NAS infants prolongs treatment
May. 17, 2018—Infants who are diagnosed with drug withdrawal after birth who are treated with medication as outpatients at home are treated three times longer than infants treated solely as inpatients, according to a new Vanderbilt study.
Study finds generic options offer limited savings for expensive drugs
May. 9, 2018—Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week.
Speakers discuss use of evidence in state health policymaking
Apr. 19, 2018—“State Health Policy: Does Evidence Really Make a Difference” was the title of the spring Research into Policy and Practice Lecture, April 11 in Light Hall. The semi-annual lecture is sponsored by the Department of Health Policy.
Study tracks impact of NAS on state Medicaid programs
Mar. 23, 2018—In the United States, one infant is born every 15 minutes with withdrawal symptoms after being exposed to opioids before birth, according to a new study published in the journal Pediatrics.
Discussing the opioid crises
Feb. 15, 2018—Stephen Patrick, MD, MPH, MS, assistant professor of Pediatrics and Health Policy in the Division of Neonatology at Monroe Carell Jr. Children’s Hospital at Vanderbilt, testified before Congress recently about the rise and impact of drug withdrawal symptoms in newborns, also known as neonatal abstinence syndrome (NAS).